Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrin-2 (CETN2) is an evolutionarily conserved, calmodulin-related EF-hand domain calcium-binding protein that functions primarily as a structural component of the centrosome. It is crucial for centriole duplication and spindle pole organization during cell division, and participates in nucleotide excision DNA repair as a component of the XPC complex. Loss or depletion of CETN2 disrupts centrosome duplication and proper mitosis, leading to genomic instability; it also impairs DNA damage recognition and repair, increasing susceptibility to conditions such as xeroderma pigmentosum. CETN2 is selectively expressed in human astrocytes where it can function as a molecular marker, and its cellular functions extend to ciliogenesis in specialized sensory cells. No approved drugs, known small-molecule antagonists, or antibodies directly target centrin-2. While disease associations exist, it is not considered a classic therapeutic target (e.g., receptor, enzyme). Thus CETN2 serves mainly as a cellular marker and as a subject for basic research into centrosome biology and DNA repair.
Not applicable; no drugs target centrin-2 directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrin-2 (CETN2).